实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (1): 47-50.doi: 10.3969/j.issn.1672-5069.2023.01.013

• 良性复发性肝内胆汁淤积症 • 上一篇    下一篇

3例良性复发性肝内胆汁淤积症患者临床特点分析

汪芾, 汪皓琪, 周怡, 周达, 方颖   

  1. 200032 上海市 复旦大学附属中山医院消化科
  • 收稿日期:2022-04-02 出版日期:2023-01-10 发布日期:2023-02-07
  • 通讯作者: 方颖,E-mail:fang.ying@zs-hospital.sh.cn
  • 作者简介:汪芾,女,24岁,医学学士,住院医师。E-mail:16301050279@fudan.edu.cn
    共同第一作者:汪皓琪,女,50岁,医学学士,主治医师。E-mail:wang.haoqi@zs-hospital.sh.cn

Clinical features of patients with benign recurrent intrahepatic cholestasis: a report of three cases

Wang Fu, Wang Haoqi, Zhou Yi, et al   

  1. Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2022-04-02 Online:2023-01-10 Published:2023-02-07

摘要: 目的 总结和分析良性复发性肝内胆汁淤积症(BRIC)患者的临床特征。方法 回顾性分析3例在复旦大学附属中山医院诊治的BRIC患者的一般情况、临床表现、实验室检查、影像学检查、病理学检查和分子遗传学检查等临床资料。结果 3例患者均为男性,首次发病年龄小于20岁,除外其他已知的可致胆汁淤积的病因;3例患者疾病均反复发作,但具有一定的自限性,发作时有黄疸和皮肤瘙痒表现,其中2例伴大便不规律、腹胀和食欲下降;实验室检查显示血清总胆红素和直接胆红素、碱性磷酸酶和总胆汁酸水平显著升高,而γ-谷氨酰转肽酶和转氨酶水平正常或轻度升高;MRCP检查均未见有肝内外胆管异常;2例肝组织病理学检查提示肝细胞明显胆汁淤积伴毛细胆管栓塞形成;3例患者均有功能预测为“潜在有害”或致病分级为“可能致病”的ATP8B1基因突变位点检出。结论 目前,BRIC病例报道较少,发病机制未完全明确,诊断较困难。临床医生应在排除其他常见肝损伤病因后,综合分析其临床表现、辅助检查和病理学检查结果进行综合临床诊断。对于临床高度怀疑BRIC的患者,应尽早行分子遗传学检查,以明确诊断,指导治疗。

关键词: 良性复发性肝内胆汁淤积症, 临床特征, ATP8B1基因突变

Abstract: Objective The aim of this study was to summarize the clinical features of patients with benign recurrent intrahepatic cholestasis (BRIC). Methods The clinical manifestations, laboratory tests, imaging, pathological examinations, and genetic analysis in three patients with BRIC in Zhongshan Hospital, Fudan University, were retrospectively reviewed. Results The three patients were all male and their initial onset ages were below 20 year old; the common symptoms of the patients were jaundice and pruritus, and two of them also experienced abdominal distension, irregular defecation, and appetite loss; serum total bilirubin, direct bilirubin, ALP and TBA levels increased significantly, while serum GGT, ALT and AST levels stayed normal or increased slightly during the disease attack duration; no abnormal intrahepatic and extrahepatic bile ducts were found in magnetic resonance cholangiopancreatography (MRCP) examination, but obvious cholestasis of hepatocytes and capillary bile duct embolism were observed in liver histopathology; the ATP8B1 gene mutation sites with functional prediction of "potentially harmful" or "likely pathogenic" in pathogenic classification were all detected in three patients; all patients were excluded from other known causes of cholestasis, and the disease was recurrent, but with self-limiting. Conclusion The BRIC is rarely reported and its pathogenesis remains unclear currently. The clinical diagnosis might be made based on clinical manifestations, ancillary tests, and pathological findings after excluding other common causes of liver damage. For patients with high suspicion of BRIC, the genetic tests should be performed as early as possible to clarify the diagnosis and guide the management.

Key words: Benign recurrent intrahepatic cholestasis, Clinical features, ATP8B1 gene mutation